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http:WHAT THIS PAPER ADDS
The International Carotid Stenting Study (ICSS) compared carotid artery stenting with CEA for patients with
recently symptomatic carotid stenosis. The aim of the present study was to determine whether there were
subgroups of surgical patients in ICSS at higher risk of stroke, myocardial infarction, or death, and whether
speciﬁc surgical factors are associated with higher risk. It was found that increasing diastolic blood pressure was
the only independent risk factor. Cautious attention to blood pressure control following symptoms attributable
to carotid stenosis could reduce the risks associated with subsequent CEA.Objectives: Carotid endarterectomy (CEA) is standard treatment for symptomatic carotid artery stenosis but
carries a risk of stroke, myocardial infarction (MI), or death. This study investigated risk factors for these procedural
complications occurring within 30 days of endarterectomy in the International Carotid Stenting Study (ICSS).
Methods: Patients with recently symptomatic carotid stenosis >50% were randomly allocated to endarterectomy
or stenting. Analysis is reported of patients in ICSS assigned to endarterectomy and limited to those in whom CEA
was initiated. The occurrence of stroke, MI, or death within 30 days of the procedure was reported by
investigators and adjudicated. Demographic and technical risk factors for these complications were analysed
sequentially in a binomial regression analysis and subsequently in a multivariable model.
Results: Eight-hundred and twenty-one patients were included in the analysis. The risk of stroke, MI, or death
within 30 days of CEA was 4.0%. The risk was higher in female patients (risk ratio [RR] 1.98, 95% CI 1.02e3.87,
p ¼ .05) and with increasing baseline diastolic blood pressure (dBP) (RR 1.30 per þ10 mmHg, 95% CI 1.02e1.66,
p ¼ .04). Mean baseline dBP, obtained at the time of randomization in the trial, was 78 mmHg (SD 13 mmHg). In
a multivariable model, only dBP remained a signiﬁcant predictor. The risk was not related to the type of surgical
reconstruction, anaesthetic technique, or perioperative medication regimen. Patients undergoing CEA stayed a
median of 4 days before discharge, and 21.2% of events occurred on or after the day of discharge.
Conclusions: Increasing diastolic blood pressure was the only independent risk factor for stroke, MI, or death
following CEA. Cautious attention to blood pressure control following symptoms attributable to carotid stenosis
could reduce the risks associated with subsequent CEA.
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Three major trials of carotid surgery versus best medical
therapy for symptomatic carotid stenosis (the North Amer-
ican Symptomatic Carotid Study, NASCET,1 the European Ca-
rotid Surgery Trial, ECST,2 and the smaller Veteran’s Affairs
Trial)3 demonstrated the beneﬁt of carotid endarterectomy
(CEA) in reducing the long-term rate of recurrent stroke.4
Since these trials published their results, CEA has become
Risk Factors For Stroke after Carotid Surgery 689the standard of care for patients with >50% symptomatic
carotid stenosis. However, despite developments in second-
ary prevention medical therapy, anaesthetic technique, sur-
gical technique, and processes of care, there remains a
signiﬁcant risk of major complications associated with CEA.5
Trials have focussed on the endpoints of stroke, myocardial
infarction (MI), and death. Stroke and MI have a signiﬁcant
adverse impact on the patient’s long-term survival e in-
hospital stroke in particular has been shown in one study to
confer a two-fold lower survival in the ﬁrst year after surgery.6
There is variability in surgical technique for CEA7,8 and
debate remains over optimal processes of care, including
perioperative antiplatelet therapy, type of arterial recon-
struction (standard, patch, or eversion CEA) and mode of
anaesthesia (general, local, or combined local-general
anaesthesia).
The International Carotid Stenting Study (ICSS) was an
international multicentre randomized controlled open clin-
ical trial that compared the newer technique of carotid
artery stenting (CAS) with CEA for patients with recently
symptomatic carotid stenosis. This study aimed to deter-
mine whether there were subgroups of surgical patients in
ICSS at higher risk of stroke, MI, or death, and whether
speciﬁc surgical factors are associated with higher risk.
METHOD
Patient selection and protocol design
The trial protocol for ICSS is published elsewhere.9 In sum-
mary, patients aged >40 years were eligible for randomiza-
tion in ICSS if they experienced symptoms within the 12
months before randomization attributable to a >50%
diameter-reducing stenosis in the region of the common ca-
rotid artery bifurcation caused by atheromatous disease.They
were required to be able to undergo either CAS or CEA. Pa-
tients were excluded if they would not be suitable for surgery
because of a surgically inaccessible distal stenosis or hostile
neck, had a major stroke with poor recovery of function, if
theywere clinically unstable (e.g. had progressive symptoms),
if their vascular anatomy rendered CAS or CEA unsuitable, if
cardiac bypass was planned within 1 month of the revascu-
larization procedure, or if there had been previous revascu-
larization of the symptomatic artery. The study was approved
by ethics committees at local sites and the Northwest Mul-
ticentre research ethics committee in the UK.
Carotid endarterectomy in ICSS was performed according
to the surgeon’s usual practice: local, general, or combined
anaesthesia was allowed for the procedure. The type of
arterial reconstruction to be carried out was not speciﬁed in
the protocol, nor was a speciﬁc peri-procedural medication
regimen. The use of shunts or patches was optional. How-
ever, all patients were required to receive “best medical
therapy,” including antiplatelet agents or anticoagulation
where appropriate, and control of vascular risk factors. In
addition to collecting the above technical information,
centres supplied demographic information about the pa-
tient at the time of enrolment into the trial, and speciﬁed
whether their general policy was to send patients to aspecialized post-procedure ward following CEA, such as an
intensive care unit, or a general surgical or medical ward.
Only patients assigned to CEA in ICSS in whom CEA was
initiated were included. Initiation of CEA was deﬁned as the
administration of either local or general anaesthesia prior to
commencement of surgery. Patients in whom CEA was
abandoned after administration of anaesthesia were included
in the analysis. Patients who crossed over without CEA or who
received CEA after an attempt at stenting were excluded.
Outcome events
Patients underwent face-to-face follow-up by a trial inves-
tigator e a neurologist or physician interested in stroke e at
30 days after surgery. Stroke, MI, or death occurring within
30 days of the procedure was reported to the central trial
ofﬁce by investigators. Stroke was deﬁned as “an acute
disturbance of focal neurological function lasting more than
24 hours resulting from intracranial vascular disturbance.” A
diagnosis of MI required two of the following: cardiac en-
zymes more than twice the upper limit of normal, a history
of chest discomfort lasting at least 30 minutes, or the
development of speciﬁc ECG abnormalities.
Outcome events were reported in detail to the central
ofﬁce by the local neurologist or stroke physician, along
with conﬁrmatory evidence (e.g. CT/MRI, blood test results,
or death certiﬁcate) where available. Major outcome events
were submitted to an independent external adjudicator,
who was masked to treatment allocation and who deter-
mined the cause, severity, and duration of the event. If this
assessment differed from the initial assessment, a second
external adjudicator reviewed the event and any differences
were resolved by consensus.
Role of the funding source
The trial funders had no role in the design of ICSS or this
analysis, data collection, drafting of the manuscript, or the
decision to publish.
Statistical analysis
Risk factors for the combined outcome of stroke, MI, or
death were examined sequentially in univariable binomial
regression analysis using maximum likelihood estimation.
Subsequent events within 30 days of the procedure were
not included in the analysis. Patients with missing data were
excluded from each relevant analysis. The risk ratio for each
factor was estimated with a 95% conﬁdence interval. Wald
tests were used for continuous and binary predictors, with
an overall likelihood ratio test for categorical predictors of
more than two levels. A multivariable model was developed
using a forward stepwise approach. Analyses were per-
formed using Stata (Stata Statistical Software: Release 12,
StataCorp 2011, College Station, TX).
Clinical trial registration
ICSS is a registered clinical trial: ISRCTN 25337470 (http://
www.controlled-trials.com/ISRCTN25337470).
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Occurrence and timing of events
Of the patients randomized in ICSS (1713), 858 were allo-
cated to surgery. One subsequently withdrew all consent
immediately after randomization, 15 crossed over to
stenting, and 21 underwent no procedure. CEA was there-
fore initiated in 821 (96.0%) patients allocated to the sur-
gery. Two patients then had their procedure aborted.Within
30 days of the procedure, 27/821 (3.3%) patients suffered a
stroke of any severity (21 ischaemic, 5 haemorrhagic, and 1
of uncertain type). Three of these strokes were fatal. One
patient who had a postoperative non-disabling stroke sub-
sequently had a disabling stroke within 30 days, and
another experienced two postoperative non-disabling
strokes within 30 days. Of these strokes, 25/27 were ipsi-
lateral to the artery being treated. No patient had a retinal
stroke. Non-fatal MI occurred in 5/821 patients (0.6%), and
one (0.1%) patient died from another cause. The combined
risk of stroke, MI, or death within 30 days of their procedure
was 4.0% (33/821). Of these events, 13/33 (39.4%) occurred
on day 0 e the day of the procedure. Patients undergoing
CEA stayed a median of 4 days before discharge, and 7/33
(21.2%) events occurred on or after their date of discharge.
Patient characteristics
Patient and procedure characteristics are summarized in
Fig. 1 along with the results of the present analysis. Of the
patients, 70.4% were male, and 52.4% were aged >70
years. Vascular risk factors were common, with treated
hyperlipidaemia in 65.7% and diabetes in 21.2%. Of the
patients, 72.4% were either current or ex-smokers. Sum-
mary statistics for continuous variables in the analysis are
given in Table 1.
Characteristics of the procedure
General or combined local-general anaesthesia was
administered to 79.2% patients undergoing CEA, and a
shunt was used in 39.5%. The type of arterial reconstruction
was “standard” primary closure in 22.1%, patch closure in
55.9%, and eversion endarterectomy in 6.0%, while vein
interposition was used in only three patients (0.4%) (data
were missing for the remaining patients). Of the patients,
726/821 (88.4%) were taking an antiplatelet agent prior to
the procedure, of whom 247 (34.0%) were prescribed dual
antiplatelet therapy.
Risk factors for stroke, MI, or death
The results of univariable analyses are presented in Fig. 1.
The risk of the combined outcome of stroke, MI, or death
within 30 days of the procedure was signiﬁcantly higher in
female patients (risk ratio [RR] 1.98, 95% CI 1.02e3.87,
p ¼ .05). Diastolic blood pressure also signiﬁcantly pre-
dicted risk (RR 1.30 for each þ10 mmHg, 95% CI 1.02e1.66,
p ¼ .04). Mean baseline diastolic blood pressure, obtained
at the time of randomization in the trial, was 78 mmHg (SD
13 mmHg).The median time from index event, prompting randomi-
zation in the trial, to CEA was 40 days (IQR 18e87 days),
and 18% underwent CEA within 14 days of the index event.
The time from the index event to the date of surgery
signiﬁcantly predicted the risk of the combined outcome of
stroke, MI, or death within 30 days of the procedure, but
the statistical signiﬁcance of this result was inﬂuenced by
one outlying patient. Removing this patient in a sensitivity
analysis resulted in a non-signiﬁcant p-value (RR 1.01 per 7
days, 95% CI 0.98e1.04, p ¼ .48).
There was no evidence that other baseline variables
including age (RR 1.08 per 5 years, 95% CI 0.89e1.30,
p ¼ .45), the patient’s level of disability (p ¼ .77), or the
degree of ipsilateral (p ¼ .58) or contralateral carotid ste-
nosis (p¼ .54) were statistically signiﬁcant predictors of risk.
Shunt use (RR 0.99, 95% CI 0.50e1.96, p ¼ .98) and
local anaesthesia only versus general or combined (RR
0.48, 95% CI 0.15e1.57, p ¼ .23) did not signiﬁcantly
predict risk. The overall comparison between types of
reconstruction (standard, eversion, patch and vein inter-
position) was not signiﬁcant (p ¼ .12). There was a
decrease in the risk of an event in centres with a policy of
sending the patient to an intensive care or other special-
ized post-procedure unit for 1 hour or more (RR 0.57, 95%
CI 0.29e1.13, p ¼ .11), although this result was not sta-
tistically signiﬁcant.
In the multivariable analysis, only baseline diastolic blood
pressure, which was available for 785/821 (95$6%) patients,
remained a signiﬁcant predictor of risk and thus the esti-
mated risk ratio is unchanged from the univariable analysis
(RR 1.30 for each þ10 mmHg, 95% CI 1.02e1.66, p ¼ .04).
Fig. 2 illustrates the increase in the observed risk of the
combined endpoint of stroke, MI, or death in ICSS patients
for patients with increasing baseline diastolic blood pressure.DISCUSSION
Summary
Of the baseline demographic and vascular risk factor vari-
ables examined, only sex and baseline diastolic blood
pressure signiﬁcantly predicted the risk of the combined
outcome of stroke, MI, or death within 30 days of CEA, with
female patients having approximately double the risk of
male patients. After adjustment in a multivariable model,
only baseline diastolic blood pressure remained a signiﬁcant
predictor of risk. There was no evidence that the surgical
technical variables, including type of anaesthesia, use of a
shunt, or type of surgical reconstruction signiﬁcantly inﬂu-
enced risk.Research in context
The ﬁnding that symptomatic women undergoing CEA in
ICSS experienced a higher risk of stroke, MI, or death
than men is broadly consistent with ﬁndings from other
randomized trials and registry data of carotid endarterec-
tomy,4,10e12 although more recent data from the Society
for Vascular Surgery Vascular Registry suggest a similar
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Figure 1. Univariable predictors of risk of stroke, death, or myocardial infarction in 821 patients undergoing CEA in whom the procedure
was initiated. AFX, amaurosis fugax; BP, blood pressure; CABG, coronary artery bypass graft; ICU, intensive care unit; MI, myocardial
infarction; TIA, transient ischaemic attack.
Risk Factors For Stroke after Carotid Surgery 691complication risk (around 4% risk of stroke, MI, or death
within 30 days of CEA).13 One potential explanation for this
may be that a smaller average carotid artery diameter in
women is associated with procedural stroke caused by in-
situ thrombosis following more technically demandingsurgery.14,12 However, sex was not an independent predic-
tor of risk in the present multivariable analysis, suggesting
that differences in other baseline patient characteristics
between male and female patients could account for the
increased operative risk in women.15
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Figure 1. (continued).
692 D. Doig et al.The association between raised baseline blood pressure
and outcome of surgery has also been demonstrated pre-
viously in a systematic review that included patients from
the European Carotid Surgery Trial.16 In ICSS, 8.3% of pa-
tients undergoing CEA experienced post-proceduralhypertension which was associated with higher baseline
blood pressure.17 Other authors have shown an association
between preoperative blood pressure, postoperative blood
pressure, and stroke or death.18,19 However, it is notable
that all of these previous studies of blood pressure and the
Table 1. Summary statistics for baseline age, systolic blood
pressure, diastolic blood pressure, total cholesterol, time from
event to index procedure, duration of surgery, and clamping
time in 821 patients undergoing CEA.
Patient characteristic No. events/
No. patientsa
Mean (SD) or
median (IQR)
Baseline age in years 33/821 70 (9)
Baseline systolic blood
pressure in mmHg
31/784 146 (24)
Baseline diastolic blood
pressure in mmHg
31/785 78 (13)
Baseline total cholesterol
in mmol/L
31/679 4.9 (1.3)
Time index event to procedure
in days
32/818 40 (18e87)
Duration of surgery in minutes 22/685 103 (79e130)
Clamping time in minutes 24/609 23 (7.5e35)
a Patients with available data.
No. events /
No. patients 3/146 8/242 10/241 10/156
0
2
4
6
8
10
12
R
is
k 
%
 (9
5%
 C
I)
<70 70-79 80-89 90+
Baseline diastolic blood pressure (mmHg)
Figure 2. Observed risk (95% conﬁdence interval) of stroke, MI, or
death with increasing categories of baseline diastolic blood
pressure.
Risk Factors For Stroke after Carotid Surgery 693risk of CEA reported only systolic blood pressure and none
reported an analysis of diastolic blood pressure, perhaps
because of an assumption that systolic blood pressure
would be a better predictor of risk. The present study
suggests that in the context of a single preoperative mea-
surement of blood pressure, diastolic blood pressure might
be the better predictor. Given the consistency of raised
blood pressure as a risk factor for perioperative events,
consideration should be given to cautious lowering of raised
blood pressure prior to CEA. However, it should be borne in
mind that overzealous lowering of blood pressure might be
hazardous in patients with impaired cerebral perfusion, for
example in those with border zone ischaemia or contralat-
eral occlusion.
Time from index symptom to procedure did not appear
to inﬂuence the risk of surgical complications. However,
most patients in ICSS underwent CEA more than 14 days
after randomization,20 whereas today there is an increasing
trend to operate on patients much earlier. In a 2012 UK
audit, one-third of patients underwent CEA within 14 days
of symptoms,7 but there is some evidence from the large
Swedish Vascular Registry that the death and stroke rate
among patients operated on within 48 hours of a qualifying
event is increased.21 The risk factors for stroke occurring in
patients operated within a few days of symptoms might be
different to those found in the present study.
Limitations
The risk of stroke, MI, or death within 30 days of surgery in
the symptomatic CEA patients was acceptably low; how-
ever, the low number of events limited ability to detect
more moderate risk factors. This also limited the number of
variables supported in a multivariable model.
Despite detailed individual patient measurements in ICSS,
only baseline and discharge blood pressures were collected
and therefore it was not possible to assess the inﬂuence of
perioperative haemodynamic control on outcome. More-
over, the protocol did not deﬁne the method or timing of
baseline blood pressure measurements, which might have
resulted in more blood pressure variability than astandardized technique. It is also possible that more
generalized measures of physiological health, such as the
patient’s American Society of Anesthesiology (ASA) grade
would be a better predictor of adverse outcomes following
CEA.22 Only 18% of patients in the present study group
received CEA within 2 weeks of symptoms, and therefore
results might not apply to patients treated soon after
symptoms.
Conclusion
Patients with higher baseline diastolic blood pressures un-
dergoing CEA in ICSS were at higher risk of stroke, MI, or
death within 30 days of the procedure. ICSS showed surgery
was safer compared with previous randomized trials of
symptomatic patients undergoing CEA, which might have
limited ability to detect other predictors of risk. Nonethe-
less, cautious attention to blood pressure control after
stroke or TIA might help to reduce the risk of serious
complications in patients undergoing subsequent CEA. The
ﬁnding that approximately one-ﬁfth of patients with an
event experienced this on or after the date of discharge
suggests a need for careful post-surgical follow-up and
attention to other vascular risk factors.
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